How do we reverse the trend of super users and reduce costs for this small, unique pool of members?
Here are some tips
ADVERTISEMENT
Idiopathic Pulmonary Fibrosis (IPF)
IPF is the progressive formation of thick or scarred tissue in the lungs, resulting in loss of oxygen. While there is currently no known cause, continued research seeks to find an answer, alongside improved diagnosis and treatment options. Learn More
How does your health system compare to others when it comes to preparing for value-based reimbursement? Recent survey findings from HFMA might provide some answers. View the survey results
Making informed and defensible decisions about which new technologies to cover, for what patients, and at what price is a major challenge.
Here's how reimbursement science might help
